At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
NRXS Neuraxis, Inc.
Market Closed 05-17 16:00:00 EDT
3.04
-0.05
-1.62%
盘后3.04
+0.000.00%
17:44 EDT
High3.08Low2.70Vol15.35K
Open3.00D1 Closing3.09Amplitude12.30%
Mkt Cap20.05MTradable Cap9.77MTotal Shares6.59M
T/O45.36KT/O Rate0.48%Tradable Shares3.21M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--
NeurAxis Announces New Medical Policy Coverage For Nearly Six Million Lives in Florida
GlobeNewswire  ·  05-16
NeurAxis Announces New Medical Policy Coverage For Nearly Six Million Lives in Florida
NeurAxis Announces New Medical Policy Coverage in North Dakota
GlobeNewswire  ·  04-23
NeurAxis Announces New Medical Policy Coverage in North Dakota
NeurAxis, Inc. (NASDAQ:NRXS) Q4 2023 Earnings Call Transcript
Insider Monkey  ·  04-12
NeurAxis, Inc. (NASDAQ:NRXS) Q4 2023 Earnings Call Transcript
NeurAxis reports Q4 results
seekingalpha  ·  04-12
NeurAxis reports Q4 results
BRIEF-NeurAxis Will Disclose In Form 10-K For Year Ended December 31, 2023, Material Weakness On Its Internal Controls Over Financial Reporting
Reuters  ·  04-10
BRIEF-NeurAxis Will Disclose In Form 10-K For Year Ended December 31, 2023, Material Weakness On Its Internal Controls Over Financial Reporting
Press Release: NeurAxis Reports Fourth Quarter and Fiscal Year 2023 Financial Results
Dow Jones  ·  04-10
Press Release: NeurAxis Reports Fourth Quarter and Fiscal Year 2023 Financial Results
NeurAxis Appoints Finance Expert, Enhances Investor Relations
TIPRANKS  ·  03-11
NeurAxis Appoints Finance Expert, Enhances Investor Relations
NeurAxis Announces Highmark BCBS Policy Coverage
GlobeNewswire  ·  03-11
NeurAxis Announces Highmark BCBS Policy Coverage
NeurAxis, Inc. Bolsters Capital with Strategic Financial Moves
TIPRANKS  ·  02-16
NeurAxis, Inc. Bolsters Capital with Strategic Financial Moves
IPO Roundup: American Healthcare REIT, BBB Foods, and more
seekingalpha  ·  02-06
IPO Roundup: American Healthcare REIT, BBB Foods, and more
Wall Street Breakfast: The Week Ahead
seekingalpha  ·  02-04
Wall Street Breakfast: The Week Ahead
NeurAxis Announces New CFO Appointment Disclosure
TIPRANKS  ·  02-01
NeurAxis Announces New CFO Appointment Disclosure
NeurAxis Announces Executive Reshuffle and New CFO Compensation
TIPRANKS  ·  02-01
NeurAxis Announces Executive Reshuffle and New CFO Compensation
NeurAxis, Inc. Issues Letter to Shareholders from Brian Carrico, President and Chief Executive Officer
GlobeNewswire  ·  2023-12-20
NeurAxis, Inc. Issues Letter to Shareholders from Brian Carrico, President and Chief Executive Officer
Neuraxis Q3 EPS $(1.35) Down From $(1.14) YoY, Sales $477.46K Down From $618.80K YoY
Benzinga  ·  2023-11-21
Neuraxis Q3 EPS $(1.35) Down From $(1.14) YoY, Sales $477.46K Down From $618.80K YoY

Introduction

Company Name.
Neuraxis, Inc.
Affiliated Markets:
AMEX
Listing Date:
--
Main Business:
NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics. NeurAxis, Inc. was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is based in Versailles, Indiana.
Issue price:
--